Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

The hOCT1 SNPs M420del and M408V alter imatinib uptake and M420del modifies clinical outcome in imatinib-treated chronic myeloid leukemia

Athina Giannoudis, Lihui Wang, Andrea L. Jorgensen, George Xinarianos, Andrea Davies, Sudeep Pushpakom, Triantafilos Liloglou, Jieying-Eunice Zhang, Gemma Austin, Tessa L. Holyoake, Letizia Foroni, Panagiotis D. Kottaridis, Martin C. Müller, Munir Pirmohamed, Richard E. Clark

Blood (2013) 121 (4): 628–637.

https://doi.org/10.1182/blood-2012-01-405035

Published: 2013

Includes: Supplemental data

Journal Articles

HLA-mismatched unrelated donors are a viable alternate graft source for allogeneic transplantation following alemtuzumab-based reduced-intensity conditioning

Adam J. Mead, Kirsty J. Thomson, Emma C. Morris, Sajir Mohamedbhai, Shari Denovan, Guillermo Orti, Adele K. Fielding, Panagiotis D. Kottaridis, Rachael Hough, Ronjon Chakraverty, David C. Linch, Stephen Mackinnon, Karl S. Peggs

Blood (2010) 115 (25): 5147–5153.

https://doi.org/10.1182/blood-2010-01-265413

Published: 2010

Includes: Supplemental data

Journal Articles

Prognostic role of PET scanning before and after reduced-intensity allogeneic stem cell transplantation for lymphoma

Jonathan R. Lambert, Jamshed B. Bomanji, Karl S. Peggs, Kirsty J. Thomson, Ronjon K. Chakraverty, Adele K. Fielding, Panagiotis D. Kottaridis, Michael Roughton, Emma C. Morris, Anthony H. Goldstone, David C. Linch, Peter J. Ell, Stephen Mackinnon

Blood (2010) 115 (14): 2763–2768.

https://doi.org/10.1182/blood-2009-11-255182

Published: 2010

Journal Articles

p53-mediated apoptosis of CLL cells: evidence for a transcription-independent mechanism

Andrew J. Steele, Archibald G. Prentice, A. Victor Hoffbrand, Birunthini C. Yogashangary, Stephen M. Hart, Elisabeth P. Nacheva, Julie D. Howard-Reeves, Veronique M. Duke, Panagiotis D. Kottaridis, Kate Cwynarski, Lyubomir T. Vassilev, R. Gitendra Wickremasinghe

Blood (2008) 112 (9): 3827–3834.

https://doi.org/10.1182/blood-2008-05-156380

Published: 2008

Includes: Supplemental data

Journal Articles

Female Gonadal Function Following Reduced Intensity Conditioning (RIC) Allogeneic Bone Marrow Transplantation for Haematological Malignancies.

Chara Kyriakou, MD, Melanie Davies, MD, Ratna Chatterjee, MD, PhD, Anna Castleton, MD, Kim Roberts, Andy Peniket, MD,PhD, Stephen Mackinnon, MD, Panagiotis D. Kottaridis, MD,PhD

Blood (2006) 108 (11): 3372.

https://doi.org/10.1182/blood.V108.11.3372.3372

Published: 2006

Journal Articles

Relationship between FLT3 mutation status, biologic characteristics, and response to targeted therapy in acute promyelocytic leukemia

Rosemary E. Gale, Robert Hills, Arnold R. Pizzey, Panagiotis D. Kottaridis, David Swirsky, Amanda F. Gilkes, Elizabeth Nugent, Kenneth I. Mills, Keith Wheatley, Ellen Solomon, Alan K. Burnett, David C. Linch, David Grimwade, for the NCRI Adult Leukaemia Working Party

Blood (2005) 106 (12): 3768–3776.

https://doi.org/10.1182/blood-2005-04-1746

Published: 2005

Includes: Supplemental data

Journal Articles

No evidence that FLT3 status should be considered as an indicator for transplantation in acute myeloid leukemia (AML): an analysis of 1135 patients, excluding acute promyelocytic leukemia, from the UK MRC AML10 and 12 trials

Rosemary E. Gale, Robert Hills, Panagiotis D. Kottaridis, Sivatharsini Srirangan, Keith Wheatley, Alan K. Burnett, David C. Linch

Blood (2005) 106 (10): 3658–3665.

https://doi.org/10.1182/blood-2005-03-1323

Published: 2005

Journal Articles

RAS mutation in acute myeloid leukemia is associated with distinct cytogenetic subgroups but does not influence outcome in patients younger than 60 years

David T. Bowen, Marion E. Frew, Robert Hills, Rosemary E. Gale, Keith Wheatley, Michael J. Groves, Stephen E. Langabeer, Panagiotis D. Kottaridis, Anthony V. Moorman, Alan K. Burnett, David C. Linch

Blood (2005) 106 (6): 2113–2119.

https://doi.org/10.1182/blood-2005-03-0867

Published: 2005

Journal Articles

Nonmyeloablative transplantation with or without alemtuzumab: comparison between 2 prospective studies in patients with lymphoproliferative disorders

Blood (2002) 100 (9): 3121–3127.

https://doi.org/10.1182/blood-2002-03-0701

Published: 2002

Journal Articles

Studies of FLT3 mutations in paired presentation and relapse samples from patients with acute myeloid leukemia: implications for the role of FLT3 mutations in leukemogenesis, minimal residual disease detection, and possible therapy with FLT3 inhibitors

Panagiotis D. Kottaridis, Rosemary E. Gale, Stephen E. Langabeer, Marion E. Frew, David T. Bowen, David C. Linch

Blood (2002) 100 (7): 2393–2398.

https://doi.org/10.1182/blood-2002-02-0420

Published: 2002

Journal Articles

High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution

Suparno Chakrabarti, Stephen Mackinnon, Raj Chopra, Panagiotis D. Kottaridis, Karl Peggs, Peter O'Gorman, Ronjon Chakraverty, Timothy Marshall, Husam Osman, Premini Mahendra, Charles Craddock, Herman Waldmann, Geoff Hale, Christopher D. Fegan, Kwee Yong, Anthony H. Goldstone, David C. Linch, Donald W. Milligan

Blood (2002) 99 (12): 4357–4363.

https://doi.org/10.1182/blood.V99.12.4357

Published: 2002

Journal Articles

Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen

Blood (2002) 99 (3): 1071–1078.

https://doi.org/10.1182/blood.V99.3.1071

Published: 2002

Journal Articles

The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials

Panagiotis D. Kottaridis, Rosemary E. Gale, Marion E. Frew, Georgina Harrison, Stephen E. Langabeer, Andrea A. Belton, Helen Walker, Keith Wheatley, David T. Bowen, Alan K. Burnett, Anthony H. Goldstone, David C. Linch

Blood (2001) 98 (6): 1752–1759.

https://doi.org/10.1182/blood.V98.6.1752

Published: 2001

Journal Articles

In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation

Blood (2000) 96 (7): 2419–2425.

https://doi.org/10.1182/blood.V96.7.2419

Published: 2000

Journal Articles

Cytomegalovirus infection and disease after autologous CD34-selected peripheral blood stem cell transplantation for multiple myeloma: no evidence of increased incidence based on polymerase-chain-reaction monitoring

Karl S. Peggs, Stuart J. Ings, Panagiotis D. Kottaridis, Kwee Yong, Catherine D. Williams, Anthony H. Goldstone, Stephen Mackinnon

Blood (2000) 96 (1): 369–371.

https://doi.org/10.1182/blood.V96.1.369

Published: 2000

NARROW

The hOCT1 SNPs M420del and M408V alter imatinib uptake and M420del modifies clinical outcome in imatinib-treated chronic myeloid leukemia

HLA-mismatched unrelated donors are a viable alternate graft source for allogeneic transplantation following alemtuzumab-based reduced-intensity conditioning

Prognostic role of PET scanning before and after reduced-intensity allogeneic stem cell transplantation for lymphoma

p53-mediated apoptosis of CLL cells: evidence for a transcription-independent mechanism

Female Gonadal Function Following Reduced Intensity Conditioning (RIC) Allogeneic Bone Marrow Transplantation for Haematological Malignancies.

Relationship between FLT3 mutation status, biologic characteristics, and response to targeted therapy in acute promyelocytic leukemia

No evidence that FLT3 status should be considered as an indicator for transplantation in acute myeloid leukemia (AML): an analysis of 1135 patients, excluding acute promyelocytic leukemia, from the UK MRC AML10 and 12 trials

RAS mutation in acute myeloid leukemia is associated with distinct cytogenetic subgroups but does not influence outcome in patients younger than 60 years

Nonmyeloablative transplantation with or without alemtuzumab: comparison between 2 prospective studies in patients with lymphoproliferative disorders

Studies of FLT3 mutations in paired presentation and relapse samples from patients with acute myeloid leukemia: implications for the role of FLT3 mutations in leukemogenesis, minimal residual disease detection, and possible therapy with FLT3 inhibitors

High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution

Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen

In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation

Cytomegalovirus infection and disease after autologous CD34-selected peripheral blood stem cell transplantation for multiple myeloma: no evidence of increased incidence based on polymerase-chain-reaction monitoring

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only